OTC · Biotechnology

Kadimastem Ltd (KMSTF) Stock

$3.21 -3.02% OTC: KMSTF Healthcare

Kadimastem Ltd, an Israeli biopharmaceutical company, focuses on pioneering regenerative medicine therapies that utilize cells originating from human embryonic stem cells, primarily targeting neurodegenerative disorders. Its developmental pipeline features AstroRx, a clinical-grade human astrocyte therapy presently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions.

Valuation

MetricValue
Price$3.21
Market Cap$9.50M
P/E Ratio-1.52
P/B Ratio-1.38
P/S Ratio0.00
EPS (TTM)$-6.33
52-Week High$9.07
52-Week Low$0.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE158.13%
ROA-803.76%
ROCE22.61%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.97
Current Ratio0.09

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-20.0M$-24.0M$-22.0M$-11.0M$-7.0M
Net Profit$-22.0M$-26.0M$-23.0M$-12.0M$-26.0M
EPS$-166.71$-119.97$-9.21$-3.97$-6.33
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$11.0M$27.0M$12.0M$8.0M$3.0M
Total Liabilities$19.0M$12.0M$12.0M$13.0M$32.0M
Cash$5.0M$23.0M$6.0M$4.0M$2.0M
Borrowings$13.0M$6.0M$7.0M$6.0M$28.0M

Latest News

Stanford Study Estimates $8.2 Million From Suspected Polymarket Bitcoin Trading Activity GuruFocus.com · Jul 16, 2026 DTCC is helping Wall Street put real stocks onchain Yahoo Finance Video · Jul 16, 2026 The Stablecoin Logic of Stripe's PayPal Bid Bankless · Jul 16, 2026 xAI sues Grok user Terry Harwood over child sexual abuse deepfakes Quartz · Jul 16, 2026 Update: Technology Slide Pushes Nasdaq, S&P 500 Lower MT Newswires · Jul 16, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-22.0M$-22.0M$-20.0M$-11.0M$-3.0M
Investing Cash Flow$0$-1.0M$-1.0M$0$1.0M
Financing Cash Flow$-1.0M$-2.0M$-2.0M$-2.0M$-1.0M
Net Cash Flow$5.0M$18.0M$-17.0M$-2.0M$-2.0M
Free Cash Flow$-22.0M$-22.0M$-21.0M$-11.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-2.18
FCF Yield-9.76%
Quick Ratio0.09
Interest Coverage-38.40
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMHVAmerican Hemp Ventures, Inc. $0.98 +0.00% — $16.47M 0.00%
ATHJFAntisense Therapeutics Limited $0.01 -76.00% -1.00 $19.64M 0.00%
EMMLFOKYO Pharma Limited $0.01 +0.00% -6.57 $22.73M 0.00%
NOXOFNoxopharm Limited $0.05 +0.00% -5.00 $14.78M 0.00%
OCELOrganicell Regenerative Medicine, Inc. $2.74 -0.27% -4.73 $19.97M 0.00%

About Kadimastem Ltd

Kadimastem Ltd, an Israeli biopharmaceutical company, focuses on pioneering regenerative medicine therapies that utilize cells originating from human embryonic stem cells, primarily targeting neurodegenerative disorders. Its developmental pipeline features AstroRx, a clinical-grade human astrocyte therapy presently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions. Additionally, the company is developing IsletRx, a clinical-grade pancreatic islet cell therapy designed to treat diabetes. Founded in 2008, Kadimastem maintains its headquarters in Ness Ziona, Israel.

Kadimastem Ltd is headquartered in IL.

Kadimastem Ltd (KMSTF) stock trades at $3.21 with a market capitalization of $9.50M. The stock is valued at a price-to-earnings (P/E) ratio of -1.52, price-to-book of -1.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.64 and $9.07, and currently trades 64.6% below its 52-week high.

On profitability, Kadimastem Ltd generates a return on equity (ROE) of 158.13% — well above the market average, a sign of a high-quality business, return on capital employed of 22.61%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.kadimastem.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides